Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a...
Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial
About this item
Full title
Author / Creator
Nakatsuji, Teruaki , Hata, Tissa R. , Tong, Yun , Cheng, Joyce Y. , Shafiq, Faiza , Butcher, Anna M. , Salem, Secilia S. , Brinton, Samantha L. , Rudman Spergel, Amanda K. , Johnson, Keli , Jepson, Brett , Calatroni, Agustin , David, Gloria , Ramirez-Gama, Marco , Taylor, Patricia , Leung, Donald Y. M. and Gallo, Richard L.
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Staphylococcus aureus
colonizes patients with atopic dermatitis (AD) and exacerbates disease by promoting inflammation. The present study investigated the safety and mechanisms of action of
Staphylococcus hominis
A9 (
Sh
A9), a bacterium isolated from healthy human skin, as a topical therapy for AD.
Sh
A9 killed
S. aureus
Alternative Titles
Full title
Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8052297
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8052297
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/s41591-021-01256-2
